From: Muscle biopsy essential diagnostic advice for pathologists
Gene | Neuromuscular disorder |
---|---|
ANO5 | Anoctaminopathy or limb girdle muscular dystrophy type R12, LGMD-R12 (in the old classification LGMD2L) (Hicks et al., 2011, Straub et al., 2018) |
CRYAB | Alpha-beta-crystallinopathy distal myopathy or alpha-beta-crystallinopathy myofibrillar myopathy (Udd 2012) |
DMD | Dystrophinopathy type Becker muscular dystrophy (de Visser et al., 1990) |
DNAJB6 | Limb girdle muscular dystrophy type D1 (LGMD1D, in the old classification LGMD1D) (Hackman et al., 2011, Harms et al., 2012, Straub et al., 2018) |
DUX4 | Facioscapulohumeral muscular dystrophy (FSHD) (Reilich et al., 2010) |
DUX4/ SMCHD1 | Facioscapulohumeral muscular dystrophy (FSHD) (Reilich et al., 2010) |
EMD | X-linked Emery-Dreifuss muscular dystrophy (Paradas et al., 2005) |
FHL1 | Reducing body myopathy (Waddell et al., 2011) |
FKRP | Fukutin-related proteinopathy or limb girdle muscular dystrophy type R9, LGMD-R9 (in the old classification LGMD2I) (Yamamoto et al., 2008, Straub et al., 2018) |
GNE | Hereditary inclusion body myopathy (hIBM) or Nonaka distal myopathy or GNE myopathy (Nishino et al., 2015) |
LAMA2 | Merosinopathy or merosin deficient congenital muscular dystrophy (Rajakulendran et al., 2011) |
LDB3/ ZASP | Markesbery-Griggs distal myopathy (ZASP myofibrillar myopathy) (Udd 2012) |
LMNA | Laminopathy or Emery-Dreifuss muscular dystrophy (Fang et al., 1997) |
MATR3 | Vocal cord and pharyngeal weakness with distal myopathy (“VCPDM”) (Palmio et al., 2016) |
MYHC-IIA | Type 3 hereditary inclusion body myopathy (hIBM3)(Narayanaswami et al., 2014) |
MYH2 | Myosinopathy (subtype) (Oldfors 2007) |
MYH7 | Laing distal myopathy (myosinopathy subtype) (Lefter et al., 2015) |
MYOT | Myotilin distal myopathy or myotilin myofibrillar myopathy (Udd 2012) |
MYOT | Myotilinopathy (Pénisson-Besnier et al., 2006) |
PABPN1 | Oculopharyngeal muscular dystrophy (Engel and Franzini-Armstrong, 2004) |
PNPLA2 | PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy (Kaneko and Aoki, 2014) |
TCAP | Telethoninopathy or limb girdle muscular dystrophy type R7, LGMD-R7 (in the old classification LGMD2G) (Moreira et al., 1997; Negrão et al., 2010; Cotta et al., 2014a, b, Straub et al., 2018, Cotta et al., 2019) |
TIA1 | Welander distal myopathy (Udd 2012) |
TNPO3 | Transportinopathy or limb girdle muscular dystrophy type D2, LGMD-D2 (in the old classification LGMD1F) (Gamez et al., 2001, Straub et al., 2018) |
TTN | Udd distal myopathy (titinopathy) (titin gene, allelic to Limb Girdle Muscular Dystrophy R10, LGMD-R10, in the old classification LGMD2J) (Udd 2012, Straub et al., 2018) |
VCP | Hereditary inclusion body myopathy with Paget’s disease of bone and frontotemporal dementia “IBMPFD” (Narayanaswami et al., 2014) |
na | Sporadic inclusion body myositis (sIBM) (Greenberg 2019) |
na | Dermatomyositis (Layzer et al., 2009) |